Shares of Kodiak Sciences Inc. (KOD) are soaring 5.01% in pre-market trading on Monday, following a significant target price increase by H.C. Wainwright. The biotechnology company's stock is reacting positively to the analyst's more optimistic outlook.

H.C. Wainwright raised its target price for Kodiak Sciences to $5 from $3, representing a substantial 67% increase. This adjustment reflects growing confidence in the company's prospects. Despite the target price hike, the firm maintained its neutral rating on the stock, suggesting a balanced view of Kodiak's potential risks and rewards.

Investors appear to be interpreting the target price increase as a positive signal about Kodiak Sciences' future performance. The pre-market surge indicates that market participants are reevaluating the stock's value in light of this new analyst perspective. As trading opens for the week, it remains to be seen whether this early momentum will carry through the regular session.